Skip to main content

Want a detailed portfolio tracker?

AIM ImmunoTech (AIM) P/E (2025 - 2026)

AIM ImmunoTech (AIM) P/E from Jun 17, 2025 to Jul 21, 2026. The TTM AIM ImmunoTech (AIM) P/E is -0.05. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of AIM ImmunoTech (AIM)

YearP/EChange
2026-0.05-71.68%
2025-0.18N/A

Comparison AIM ImmunoTech (AIM) P/E with competitors

AIM ImmunoTech (AIM) P/E is -0.05.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-103.38%
NBYStablecoin Development Corp0.00-108.55%
ENLVEnlivex Ltd0.07-248.72%
FGENFibroGen Inc0.24-577.23%
CHRSCoherus Biosciences Inc0.85-1786.98%
FBIOFortress Biotech Inc0.95-1986.80%
ORMPOramed Pharmaceuticals Inc1.50-3088.26%
AGENAgenus Inc3.01-6083.47%
INVAInnoviva Inc3.15-6370.57%
VXRTVaxart Inc3.55-7157.30%
CRMDCorMedix Inc3.63-7313.77%
CVACCureVac N.V.4.45-8938.52%
GLPGGalapagos NV4.86-9760.05%
SRPTSarepta Therapeutics Inc4.88-9806.17%
ABEOAbeona Therapeutics Inc5.39-10811.01%
ABUSArbutus Biopharma Corp5.60-11224.75%
ZVRAZevra Therapeutics Inc5.89-11804.51%
SPROSpero Therapeutics Inc6.23-12482.88%
CGENCompugen Ltd6.31-12652.87%
RIGLRigel Pharmaceuticals6.87-13762.48%
SLXNSilexion Therapeutics Corp7.30-14605.48%
OMEROmeros Corporation9.26-18507.51%
AUPHAurinia Pharmaceuticals Inc9.58-19156.06%
PLXProtalix BioTherapeutics Inc10.89-21752.64%
ACADAcadia Pharmaceuticals Inc11.73-23417.76%
TBPHTheravance Biopharma Inc12.26-24478.66%
ADMAAdma Biologics Inc12.42-24788.82%
HRMYHarmony Biosciences Holdings Inc13.82-27576.27%
SABSSAB Biotherapeutics Inc14.14-28204.54%
NAGENiagen Bioscience Inc14.82-29560.29%
INCYIncyte Corp15.82-31557.23%
REGNRegeneron Pharmaceuticals Inc15.86-31625.03%
PBYIPuma Biotechnology Inc17.32-34525.80%
CPRXCatalyst Pharmaceuticals Inc17.44-34771.55%
EXELExelixis Inc17.54-34967.78%
TGTXTG Therapeutics Inc18.97-37806.92%
MDXGMimedx Group Inc20.55-40961.00%
XOMAXOMA Royalty Corp22.87-45578.98%
ARGXArgen X SE24.30-48408.78%
CTMXCytomX Therapeutics Inc24.82-49448.80%
XOMAOXOMA Royalty Corp25.34-50490.02%
HALOHalozyme Therapeutics Inc25.62-51044.53%
XOMAPXOMA Royalty Corp25.67-51136.78%
VRTXVertex Pharmaceuticals Inc27.99-55758.54%
RPRXRoyalty Pharma plc - Class A28.69-57135.96%
SLNOSoleno Therapeutics Inc29.02-57787.69%
ASNDAscendis Pharma A/S30.09-59915.46%
LGNDLigand Pharmaceuticals Inc - Class B37.91-75475.87%
APLSApellis Pharmaceuticals Inc39.02-77681.18%
BMRNBiomarin Pharmaceutical Inc42.21-84024.72%
KRYSKrystal Biotech Inc45.34-90250.95%
ONCBeiGene Ltd69.54-138358.92%
PHARPharming Group N.V.75.03-149264.37%
TECHBio-Techne Corp101.96-202811.65%
VCELVericel Corp109.92-218643.45%
ALNYAlnylam Pharmaceuticals Inc117.96-234635.90%
GMABGenmab140.29-279023.36%
TLXTelix Pharmaceuticals Ltd162.15-322489.09%
CORTCorcept Therapeutics Inc212.86-423299.15%